Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2015-11-27 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BREST (29200), Finistere
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE RECOUVRANCE : revenue, balance sheet and financial ratios
PHARMACIE DE RECOUVRANCE is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BREST (29200),
this company of category PME
shows in 2024 a net income positive of 340 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE RECOUVRANCE (SIREN 814945283)
Indicator
2024
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
340 004 €
258 076 €
186 012 €
161 626 €
151 991 €
176 750 €
75 155 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DE RECOUVRANCE generates positive net income of 340 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 75 k€ -> 340 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
340 004 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 113%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 41%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
112.786%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
41.335%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE RECOUVRANCE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2024
Debt ratio
1708.754
796.835
508.442
349.079
245.601
170.688
112.786
Financial autonomy
4.806
9.894
14.427
19.393
25.215
32.324
41.335
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
112.792024
2021
2022
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average-11 pts over 3 years
In 2024, the debt ratio of PHARMACIE DE RECOUVRANCE (112.79) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
41.34%2024
2021
2022
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+15 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DE RECOUVRANCE (41.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 193.66. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
193.655
Liquidity indicators evolution PHARMACIE DE RECOUVRANCE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2024
Liquidity ratio
155.276
178.933
167.235
161.691
166.983
193.069
193.655
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
193.662024
2021
2022
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good+15 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE RECOUVRANCE (193.66) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DE RECOUVRANCE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE RECOUVRANCE is estimated at
4 746 707 €
(range 3 305 531€ - 7 101 345€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
3305k€4746k€7101k€
4 746 707 €Range: 3 305 531€ - 7 101 345€
NAF 5 année 2024
Valuation method used
Net Income Multiple
340 004 €
×
14.0x
=4 746 707 €
Range: 3 305 532€ - 7 101 346€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE RECOUVRANCE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE RECOUVRANCE
What is the revenue of PHARMACIE DE RECOUVRANCE ?
The revenue of PHARMACIE DE RECOUVRANCE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE RECOUVRANCE profitable?
Yes, PHARMACIE DE RECOUVRANCE generated a net profit of 340 k€ in 2024.
Where is the headquarters of PHARMACIE DE RECOUVRANCE ?
The headquarters of PHARMACIE DE RECOUVRANCE is located in BREST (29200), in the department Finistere.
Where to find the tax return of PHARMACIE DE RECOUVRANCE ?
The tax return of PHARMACIE DE RECOUVRANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE RECOUVRANCE operate?
PHARMACIE DE RECOUVRANCE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart